Clinical Trial Update: Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating radiation therapy and temozolomide followed by temozolomide and Poly ICLC in newly diagnosed glioblastoma multiforme has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Poly-ICLC (poly-ICLC)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2014-07-16